These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 33612481)

  • 21. Cinnamaldehyde induces cell apoptosis mediated by a novel circular RNA hsa_circ_0043256 in non-small cell lung cancer.
    Tian F; Yu CT; Ye WD; Wang Q
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1260-1266. PubMed ID: 28958934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hsa_circ_0002483 inhibited the progression and enhanced the Taxol sensitivity of non-small cell lung cancer by targeting miR-182-5p.
    Li X; Yang B; Ren H; Xiao T; Zhang L; Li L; Li M; Wang X; Zhou H; Zhang W
    Cell Death Dis; 2019 Dec; 10(12):953. PubMed ID: 31844042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circular RNA circ-CMPK1 contributes to cell proliferation of non-small cell lung cancer by elevating cyclin D1 via sponging miR-302e.
    Cui D; Qian R; Li Y
    Mol Genet Genomic Med; 2020 Feb; 8(2):e999. PubMed ID: 31863641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circular RNA circ-PTEN elevates PTEN inhibiting the proliferation of non-small cell lung cancer cells.
    Wang Y; Wang Z; Lu J; Zhang H
    Hum Cell; 2021 Jul; 34(4):1174-1184. PubMed ID: 33821441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hsa_circ_0018818 knockdown suppresses tumorigenesis in non-small cell lung cancer by sponging miR-767-3p.
    Xu X; Zhou X; Gao C; Cui Y
    Aging (Albany NY); 2020 May; 12(9):7774-7785. PubMed ID: 32357143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CircRNA_101237 promotes NSCLC progression via the miRNA-490-3p/MAPK1 axis.
    Zhang ZY; Gao XH; Ma MY; Zhao CL; Zhang YL; Guo SS
    Sci Rep; 2020 Jun; 10(1):9024. PubMed ID: 32494004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p.
    Dong Y; Xu T; Zhong S; Wang B; Zhang H; Wang X; Wang P; Li G; Yang S
    Life Sci; 2019 Dec; 239():116984. PubMed ID: 31647948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circular RNA circ-LDLRAD3 serves as an oncogene to promote non-small cell lung cancer progression by upregulating SLC1A5 through sponging miR-137.
    Xue M; Hong W; Jiang J; Zhao F; Gao X
    RNA Biol; 2020 Dec; 17(12):1811-1822. PubMed ID: 32658600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel circular RNA, hsa_circ_0030998 suppresses lung cancer tumorigenesis and Taxol resistance by sponging miR-558.
    Li X; Feng Y; Yang B; Xiao T; Ren H; Yu X; Li L; Li M; Zhang W
    Mol Oncol; 2021 Aug; 15(8):2235-2248. PubMed ID: 33190405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway.
    Xing Y; Liu Y; Liu T; Meng Q; Lu H; Liu W; Hu J; Li C; Cao M; Yan S; Huang J; Wang T; Cai L
    Cell Commun Signal; 2018 Jul; 16(1):43. PubMed ID: 30064446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circular RNA hsa_circ_0085131 is involved in cisplatin-resistance of non-small-cell lung cancer cells by regulating autophagy.
    Kong R
    Cell Biol Int; 2020 Sep; 44(9):1945-1956. PubMed ID: 32449799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circ_0014130 Participates in the Proliferation and Apoptosis of Nonsmall Cell Lung Cancer Cells via the miR-142-5p/IGF-1 Axis.
    Wang M; Shi J; Jiang H; Xu K; Huang Z
    Cancer Biother Radiopharm; 2020 Apr; 35(3):233-240. PubMed ID: 31916848
    [No Abstract]   [Full Text] [Related]  

  • 33. Hsa_circ_0003288 facilitates tumor progression by targeting miR-145 in non-small cell lung cancer cells.
    Pan LN; Ma YF; Hu JA; Xu ZH
    Cancer Biomark; 2022; 35(4):349-357. PubMed ID: 35001875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CircRNA hsa_circ_100395 regulates miR-1228/TCF21 pathway to inhibit lung cancer progression.
    Chen D; Ma W; Ke Z; Xie F
    Cell Cycle; 2018; 17(16):2080-2090. PubMed ID: 30176158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paclitaxel promotes lung cancer cell apoptosis via MEG3-P53 pathway activation.
    Xu J; Su C; Zhao F; Tao J; Hu D; Shi A; Pan J; Zhang Y
    Biochem Biophys Res Commun; 2018 Sep; 504(1):123-128. PubMed ID: 30173893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4/MADD activation.
    Gao P; Wang Z; Hu Z; Jiao X; Yao Y
    J Cell Biochem; 2020 Mar; 121(3):2632-2642. PubMed ID: 31680319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non-Small Cell Lung Cancer Xenograft Models.
    Hai J; Sakashita S; Allo G; Ludkovski O; Ng C; Shepherd FA; Tsao MS
    J Thorac Oncol; 2015 Aug; 10(8):1172-80. PubMed ID: 26200271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circ_MDM2_000139, Circ_ATF2_001418, Circ_CDC25C_002079, and Circ_BIRC6_001271 Are Involved in the Functions of XAV939 in Non-Small Cell Lung Cancer.
    Yu H; Xu L; Liu Z; Guo B; Han Z; Xin H
    Can Respir J; 2019; 2019():9107806. PubMed ID: 31885751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circular RNA CELF1 drives immunosuppression and anti-PD1 therapy resistance in non-small cell lung cancer via the miR-491-5p/EGFR axis.
    Ge W; Chi H; Tang H; Xu J; Wang J; Cai W; Ma H
    Aging (Albany NY); 2021 Nov; 13(22):24560-24579. PubMed ID: 34788230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circular RNA circ_0020123 promotes non-small cell lung cancer progression by acting as a ceRNA for miR-488-3p to regulate ADAM9 expression.
    Wan J; Hao L; Zheng X; Li Z
    Biochem Biophys Res Commun; 2019 Jul; 515(2):303-309. PubMed ID: 31153639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.